Ex vivo COX‐1 and COX‐2 inhibition in equine blood by phenylbutazone, flunixin meglumine, meloxicam and firocoxib: Informing clinical NSAID selection-Reference-Cited by-同舟云学术

Ex vivo COX‐1 and COX‐2 inhibition in equine blood by phenylbutazone, flunixin meglumine, meloxicam and firocoxib: Informing clinical NSAID selection

Author:

Fogle C.¹^ORCID,Davis J.²^ORCID,Yechuri B.³,Cordle K.⁴,Marshall J.⁵,Blikslager A.¹^ORCID

Affiliation:

1. Department of Clinical Sciences College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA

2. Department of Biomedical Sciences and Pathobiology Virginia‐Maryland College of Veterinary Medicine Blacksburg Virginia USA

3. University of British Columbia Vancouver British Columbia Canada

4. Department of Molecular and Biomedical Sciences College of Veterinary Medicine North Carolina State University Raleigh North Carolina USA

5. Weipers Centre Equine Hospital University of Glasgow Glasgow UK

Funder

Bijou Memorial fund

Callie Fogle, startup funds provided by NC State University

Merial Summer Scholars Program

Publisher

Wiley

Subject

Equine

Link

Reference27 articles.

5. Effect of firocoxib or flunixin meglumine on recovery of ischemic‐injured equine jejunum;Cook V.L.;J. Am. Vet. Med. Assoc.,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献